文献速递角膜与眼表疾病眼底病与葡萄膜炎青光眼

带状疱疹眼病的临床表现及视力丧失危险因素

Herpes Zoster Ophthalmicus Clinical Presentation and Risk Factors for Loss of Vision.
PubMed 文献 · Am J Ophthalmol · 2021-02-08

该回顾性队列纳入2006至2016年单中心869例急性带状疱疹眼病患者,中位随访6.3年。约9.6%发生中度视力丧失,3.6%发生重度视力丧失,主要原因为角膜瘢痕。多因素分析显示高龄、免疫抑制、就诊时视力差及葡萄膜炎与重度永久性视力丧失相关。

要点

  • 急性带状疱疹眼病患者中约1/10可发生中度或重度视力丧失。
  • 角膜瘢痕是视力丧失的主要原因,占94.0%。
  • 高龄、免疫抑制、葡萄膜炎与重度永久性视力丧失相关。

核心结论

  • 带状疱疹眼病患者中约1/10可发生中度或重度视力丧失,主要原因为角膜瘢痕。
  • 高龄、免疫抑制和葡萄膜炎与带状疱疹眼病继发的重度永久性视力丧失相关。

研究设计与样本

  • 回顾性队列研究,纳入2006至2016年单中心所有急性带状疱疹眼病患者,共869例,中位随访6.3年(四分位距3.7-8.9年)。

主要发现

  • 737例(84.8%)在就诊时或首月内诊断眼部受累,最常见为结膜炎(76.1%)、角膜炎(51.2%)和葡萄膜炎(47.6%)。
  • 带状疱疹眼病继发中度视力丧失(≤20/50)83眼(9.6%),重度视力丧失(≤20/200)31眼(3.6%)。
  • 视力丧失原因包括角膜瘢痕(94.0%)、角膜穿孔(4.8%)和继发性青光眼(1.2%)。
  • 多因素分析显示重度视力丧失与高龄(HR 1.059,P = .001)、免疫抑制(HR 3.125,P = .028)、就诊时视力差(HR 2.821,P = .002)和葡萄膜炎(HR 4.777,P = .004)相关。

临床怎么用

  • 对急性带状疱疹眼病患者应评估高龄、免疫抑制、就诊视力及葡萄膜炎等危险因素以识别重度视力丧失高危者。
  • 角膜瘢痕是带状疱疹眼病视力丧失的主要 cause,临床随访中需关注角膜并发症。

局限性

  • 单中心回顾性队列研究,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine the rate of moderate and severe vision loss following herpes zoster ophthalmicus (HZO) and to identify associated factors. DESIGN: Retrospective cohort study. METHODS: All subjects with acute HZO seen at a single center from 2006 to 2016 were included in the study. The primary outcome measure was the proportion of individuals with moderate and/or severe loss of vision following an acute episode of HZO. Secondary outcome measures included causes and factors associated with permanent loss of vision owing to HZO. RESULTS: A total of 869 patients with acute HZO were identified with a median follow-up time of 6.3 years (interquartile range 3.7-8.9 years). Ocular involvement of HZO was diagnosed at or within the first month of presentation in 737 individuals (84.8%). The most common sites of ocular involvement were conjunctivitis (76.1%), followed by keratitis (51.2%) and uveitis (47.6%). Moderate vision loss (≤20/50) secondary to HZO occurred in 83 eyes (9.6%) while severe vision loss (≤20/200) occurred in 31 eyes (3.6%). Causes of loss of vision included corneal scarring (94.0%), corneal perforation (4.8%), and secondary glaucoma (1.2%). Severe vision loss was associated with older age (hazard ratio [HR] 1.059, P = .001), immunosuppression (HR 3.125, P = .028), poor presenting visual acuity (HR 2.821, P = .002), and uveitis (HR 4.777, P = .004) on multivariate analysis. CONCLUSIONS: Among individuals with HZO, approximately 1 in 10 individuals may develop moderate or severe vision loss, primarily owing to corneal scarring. Older age, immunosuppression, and uveitis are associated with severe permanent loss of vision secondary to HZO.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Niederer RL, Meyer JJ, Liu K, et al. Herpes Zoster Ophthalmicus Clinical Presentation and Risk Factors for Loss of Vision. Am J Ophthalmol. 2021. PMID: 33571476. doi:10.1016/j.ajo.2021.02.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。